+1. This mirrors my journey exactly. The VENDOR RULES Read discussion here is so valuable.

Clinical perspective on VENDOR RULES Read before posting ( Jan:

I have managed over 200 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that the medication works best as part of a comprehensive approach.

For this specific question, I would recommend: getting comprehensive baseline labs first.

Want to share my personal experience related to VENDOR RULES Read before since I think it might help others in a similar situation.

I started my GLP-1 journey in October 2024 at 253 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.

Now, 8 months later: I am down 88 lbs, my labs have normalized, and I am off 2 of my 3 medications. The VENDOR RULES Read aspect specifically was something that made a big difference in my journey.

This community helped me every step of the way.

hyun_seoul — that is really helpful context on VENDOR RULES Read. Follow-up question: did you experience any side effects during this phase?

I am in a similar situation (about to start) and trying to set realistic expectations.

To answer Dr.NutriCornell's question specifically:

From a clinical standpoint, VENDOR RULES Read before is something I discuss with patients regularly.

The short answer: discuss this specific situation with your prescribing provider.

The longer answer involves weighing the risk-benefit ratio for your individual situation, which I am happy to elaborate on if helpful.